Latest News
Search News
Barts Cancer Institute teams awarded nearly £3m from Cancer Research UK to seek novel cancer therapy targets
11th March 2026
Professor Michelle Lockley and Dr Oliver Pearce have both been awarded prestigious Programme Foundation Awards from Cancer Research UK, worth nearly £1.5 million each, to support the work of their research groups at Barts Cancer Institute, Queen Mary University of London.
Read more
NHS changes guidelines for bladder cancer patients following new clinical trial results
12th February 2026
Thousands of people with advanced bladder cancer across the UK will now receive three rather than six chemotherapy cycles after Queen Mary University of London-led research led to a change to NHS treatment guidelines. For patients, this means fewer toxic side effects and a better quality of life during treatment.
Read more
Video: Driving Discoveries for Tomorrow’s Cancer Care
4th February 2026
Today, on World Cancer Day, join us as we go behind the scenes at Queen Mary’s Barts Cancer Institute (BCI) and meet the people who are making progress possible.
Read more
New approach offers hope for people with rare eye cancer
21st January 2026
A more active approach to monitoring and treating people with a rare eye cancer (known as uveal melanoma) that has spread to the liver could help some patients to live longer, according to researchers at Barts Cancer Institute, Queen Mary University of London. The findings, from a retrospective study of the largest UK cohort of patients with this condition to date, offer an encouraging sign of progress in this rare and difficult-to-treat cancer.
Read more
Celebrating the BCI’s highlights of 2025
17th December 2025
Join us as we look back at some highlights of Barts Cancer Institute’s news stories this year.
Read more
Discovery reveals new understanding of cancer-driving proteins in rare brain tumours and beyond
7th November 2025
Scientists have discovered that a single letter change in a gene called PRKCA drives a rare and hard-to-treat brain cancer, chordoid glioma, through an entirely unexpected mechanism. The findings could open up new ways to design targeted treatments for this difficult-to-treat disease, and possibly for other cancers involving the same gene.
Read more